LL-37
A germ-fighter your immune system already makes on its own. It's a cathelicidin-derived antimicrobial peptide used for chronic infections and biofilm-associated issues.
LL-37: A germ-fighter your immune system already makes on its own. It's a cathelicidin-derived antimicrobial peptide used for chronic infections and biofilm-associated issues. LL-37 is an antimicrobial peptide your innate immune system already makes.
LL-37 is an antimicrobial peptide your innate immune system already makes. People use it for chronic infections, biofilms (bacterial slime that resists antibiotics), and immune support. Strong effect in lab data, less data in humans.
Not prescribed in conventional medicine.
Who it's for
- →Users with chronic biofilm-associated infections
- →Wound-healing contexts
- →Stack add-on for aggressive immune protocols
What to expect
- Week 1
Subtle. Mild flu-like symptoms in first few doses for some users.
- Week 4
Full cycle. Reassess infection markers.
- Week 8
Off-cycle.
Looking at LL-37? Your next 3 steps
- 1Work out your exact dose
Vial size + BAC water turns into the exact units to draw for LL-37.
Open calculator → - 2See what to stack & monitor
The companion supplements and the bloodwork worth tracking on this kind of protocol.
Bloodwork guide → - 3Save it & ask the Coach
A free account saves your stack; membership adds the stack-aware AI Coach.
Create free account →
How it works (mechanism)
Cathelicidin-derived antimicrobial peptide (the human cathelicidin family's only member). Disrupts bacterial membranes through pore formation and modulates innate immune signaling.
Dosing protocol
Stacks well with
Side effects
When NOT to use
- ⚠Mast cell activation syndrome (MCAS)
- ⚠Pregnancy / nursing
Bloodwork to monitor
- • CBC if running long courses
Common mistakes
- • Treating it as a substitute for antibiotics (it's adjunct, not replacement)
- • Pushing dose in MCAS-prone users
- • Skipping the cycle break
Drug & supplement interactions
- ⚠Mast cell activation syndrome (MCAS): may worsen, avoid
- ⚠Limited documented interactions
New to LL-37? Grab the starter checklist.
Drop your email and we'll send the one-page first-cycle starter checklist, plus a heads-up if LL-37 changes legal status. No account needed.
No spam. No selling your email. Just the checklist and the occasional reclassification alert.
Ask the Coach anything about LL-37 or your own stack. This is it working.
Trained only on Pepdex content. Does the dose math, flags interactions, knows your stack. Won't push vendors, won't pretend to be a doctor.
Get the Coach, $7.99/mo →Frequently asked
What is LL-37?+
Is LL-37 FDA approved?+
Is LL-37 legal?+
Is LL-37 banned by WADA?+
Are you still natty after taking LL-37?+
Do doctors prescribe LL-37?+
What's the typical dose of LL-37?+
What are the side effects of LL-37?+
How long until LL-37 starts working?+
What can you stack with LL-37?+
Where do people get LL-37?+
LL-37 vs Thymosin Alpha-1 (Tα1), which is better?+
Head-to-head with LL-37
More in Immune
Immune-system peptide. Approved in many countries for hepatitis B/C and as adjunct to chemotherapy. Used here for chronic immune issues and post-illness recovery.
Endogenous 28-amino-acid neuropeptide. Modulates immune function and inflammation. Used in CIRS (chronic inflammatory response syndrome) protocols and biotoxin exposure recovery, popularized by Dr. Ritchie Shoemaker.
Calms inflammation in the gut and skin. A tripeptide fragment of alpha-MSH used for gut conditions and skin inflammation.
Used to rebuild a weakened immune system, mainly in older or post-illness patients. A polypeptide complex extracted from calf thymus and distinct from Thymosin Alpha-1, used in Russian and Eastern European clinical practice for immune restoration in elderly patients and post-illness recovery.